Correlation Between Astellas Pharma and Organon

Can any of the company-specific risk be diversified away by investing in both Astellas Pharma and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Astellas Pharma and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Astellas Pharma and Organon Co, you can compare the effects of market volatilities on Astellas Pharma and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astellas Pharma with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Astellas Pharma and Organon.

Diversification Opportunities for Astellas Pharma and Organon

0.18

Correlation Coefficient

Astellas Pharma  Organon

Average diversification

The 3 months correlation between Astellas and Organon is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Astellas Pharma and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Astellas Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astellas Pharma are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Astellas Pharma i.e., Astellas Pharma and Organon go up and down completely randomly.

Pair Corralation between Astellas Pharma and Organon

Assuming the 90 days horizon Astellas Pharma is expected to generate 0.44 times more return on investment than Organon. However, Astellas Pharma is 2.27 times less risky than Organon. It trades about 0.03 of its potential returns per unit of risk. Organon Co is currently generating about 0.01 per unit of risk. If you would invest  969.00  in Astellas Pharma on December 28, 2024 and sell it today you would earn a total of  21.00  from holding Astellas Pharma or generate 2.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Astellas Pharma  vs.  Organon Co

Astellas Pharma

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Astellas Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong primary indicators, Astellas Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Organon

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Organon Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Organon is not utilizing all of its potentials. The new stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Astellas Pharma and Organon

The main advantage of trading using opposite Astellas Pharma and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Astellas Pharma position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.

The idea behind Astellas Pharma and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.